In response
- PMID: 24898982
- PMCID: PMC4047754
- DOI: 10.4269/ajtmh.14-0040b
In response
Comment on
-
Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama.Am J Trop Med Hyg. 2013 Sep;89(3):557-563. doi: 10.4269/ajtmh.12-0736. Epub 2013 Jul 15. Am J Trop Med Hyg. 2013. PMID: 23857024 Free PMC article. Clinical Trial.
-
Topical paromomycin and gentamicin for new world cutaneous leishmaniasis in Panama.Am J Trop Med Hyg. 2014 Jun;90(6):1191. doi: 10.4269/ajtmh.14-0040a. Am J Trop Med Hyg. 2014. PMID: 24898981 Free PMC article. No abstract available.
References
-
- Garnier T, Croft SL, 2002. Topical treatment for cutaneous leishmasniasis. Curr Opin Investig Drugs 3: 538–544 - PubMed
-
- International Journal of Toxicology , 1985. Final report on the safety assessment of benzethonium chloride and methylbenzethonium chloride. Int J Toxicol 4: 65–106
-
- Grogl M, Schuster BG, Ellis WY, Berman JD, 1999. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. J Parasitol 85: 354–359 - PubMed
-
- Sosa N, Capitán Z, Nieto J, Nieto M, Calzada J, Paz H, Spadafora C, Kreishman-Deitrick M, Kopydlowski K, Ullman D, McCarthy WF, Ransom J, Berman J, Scott C, Grogl M, 2013. Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama. Am J Trop Med Hyg 89: 557–563 - PMC - PubMed
-
- Soto J, Berman J, 2013. Reply to Monge-Maillo et al. Clin Infect Dis 57: 1503–1504 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
